Nautilus Biotechnology, Inc.
NAUT
$0.6884
-$0.0246-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.02% | -3.77% | 17.58% | 20.80% | 12.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.10% | 0.13% | 9.32% | 19.64% | 22.68% |
| Operating Income | 0.10% | -0.13% | -9.32% | -19.64% | -22.68% |
| Income Before Tax | -3.35% | -3.58% | -13.93% | -25.16% | -26.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.35% | -3.58% | -13.93% | -25.16% | -26.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.35% | -3.58% | -13.93% | -25.16% | -26.96% |
| EBIT | 0.10% | -0.13% | -9.32% | -19.64% | -22.68% |
| EBITDA | -0.52% | 0.12% | -9.16% | -19.33% | -21.86% |
| EPS Basic | -2.72% | -3.15% | -13.24% | -24.65% | -26.70% |
| Normalized Basic EPS | -2.95% | -3.15% | -13.24% | -24.50% | -37.43% |
| EPS Diluted | -2.72% | -3.15% | -13.24% | -24.65% | -26.70% |
| Normalized Diluted EPS | -2.95% | -3.15% | -13.24% | -24.50% | -37.43% |
| Average Basic Shares Outstanding | 0.65% | 0.42% | 0.57% | 0.44% | 0.16% |
| Average Diluted Shares Outstanding | 0.65% | 0.42% | 0.57% | 0.44% | 0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |